寻找新的抗真菌药物用于治疗加密菌病
Naira Sulany Oliveira de Sousa1, Juan Diego Ribeiro de Almeida2, Hagen Frickmann3,4
1Programa de Pós-Graduação em Biodiversidade e Biotecnologia da Rede BIONORTE, Manaus, AM, Brasil.
Revista da Sociedade Brasileira de Medicina Tropical
|July 26, 2023
概括
对加密球菌感染的有限的抗真菌选择需要新的治疗方法. 本综述探讨了新的药物发现方法,以对抗真菌耐药性并改善患者的治疗结果.
科学领域:
- 菌类学和传染病的研究
- 药理学和药物发现
背景情况:
- 由于有限的抗真菌药物库,加密球菌感染带来了显著的死亡风险.
- 标准的治疗方法,如安福特里辛B和细胞素是有毒的,昂贵的,在低收入环境中往往是不可用的.
- 可纳虽然可获得,但有助于抗真菌耐药性和治疗复发.
研究的目的:
- 审查目前针对加密球菌病的抗真菌疗法的局限性.
- 探索发现新型抗真菌剂和助剂的新兴策略.
- 突出需要具有杀菌作用,低毒性和中枢神经系统透的药物.
主要方法:
- 审查关于加密球菌病及其治疗的现有文献.
- 对常规抗真菌药物限制和耐药机制的分析.
- 探索药物发现方法,包括天然产品选,结构改造,药物重新定位和组合疗法.
主要成果:
- 传统的抗真菌药物对加密球菌有显著的缺点,包括毒性,成本和新兴的耐药性.
- 新的抗真菌剂必须克服密码球菌的毒性机制,并具有杀菌性质.
- 目前正在研究各种策略,以开发更有效和更容易获得的治疗方法.
结论:
- 目前针对加密球菌的抗真菌治疗方法不足,导致高死亡率.
- 新型治疗策略对于应对耐药性和治疗失败的挑战至关重要.
- 对替代疗法和组合疗法的持续研究有望改善加密球菌感染的管理.
相关概念视频
Fungal Phylum Microsporidia
41
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
41
Fungal Group Zygomycota
43
Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
43
Antimicrobial Effectiveness
49
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
49


